1. Home
  2. SLRC vs INMD Comparison

SLRC vs INMD Comparison

Compare SLRC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRC
  • INMD
  • Stock Information
  • Founded
  • SLRC 2007
  • INMD 2008
  • Country
  • SLRC United States
  • INMD Israel
  • Employees
  • SLRC N/A
  • INMD N/A
  • Industry
  • SLRC Finance/Investors Services
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SLRC Finance
  • INMD Health Care
  • Exchange
  • SLRC Nasdaq
  • INMD Nasdaq
  • Market Cap
  • SLRC 889.2M
  • INMD 957.6M
  • IPO Year
  • SLRC 2010
  • INMD 2019
  • Fundamental
  • Price
  • SLRC $14.36
  • INMD $16.00
  • Analyst Decision
  • SLRC Hold
  • INMD Hold
  • Analyst Count
  • SLRC 6
  • INMD 6
  • Target Price
  • SLRC $15.96
  • INMD $16.81
  • AVG Volume (30 Days)
  • SLRC 263.8K
  • INMD 691.7K
  • Earning Date
  • SLRC 11-04-2025
  • INMD 10-29-2025
  • Dividend Yield
  • SLRC 11.30%
  • INMD N/A
  • EPS Growth
  • SLRC N/A
  • INMD 46.63
  • EPS
  • SLRC 1.63
  • INMD 2.54
  • Revenue
  • SLRC $222,445,000.00
  • INMD $401,561,000.00
  • Revenue This Year
  • SLRC N/A
  • INMD N/A
  • Revenue Next Year
  • SLRC $0.23
  • INMD $5.30
  • P/E Ratio
  • SLRC $8.91
  • INMD $5.90
  • Revenue Growth
  • SLRC N/A
  • INMD N/A
  • 52 Week Low
  • SLRC $13.64
  • INMD $13.14
  • 52 Week High
  • SLRC $17.94
  • INMD $19.85
  • Technical
  • Relative Strength Index (RSI)
  • SLRC 20.55
  • INMD 65.74
  • Support Level
  • SLRC $15.00
  • INMD $14.90
  • Resistance Level
  • SLRC $15.31
  • INMD $15.47
  • Average True Range (ATR)
  • SLRC 0.31
  • INMD 0.41
  • MACD
  • SLRC -0.11
  • INMD 0.05
  • Stochastic Oscillator
  • SLRC 3.74
  • INMD 69.39

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: